BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JY, Park T, Hong E, Amatya R, Park KA, Park YH, Min KA, Jin M, Lee S, Hwang S, Roh GS, Shin MC. Genetic engineering of novel super long-acting Exendin-4 chimeric protein for effective treatment of metabolic and cognitive complications of obesity. Biomaterials 2020;257:120250. [PMID: 32736262 DOI: 10.1016/j.biomaterials.2020.120250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharm Sin B 2021;11:2396-415. [PMID: 34522592 DOI: 10.1016/j.apsb.2021.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Dobres S, Mula G, Sauer J, Zhu D. Applications of 3D Printed Chimeric DNA Biomaterials. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.001] [Reference Citation Analysis]
3 Ahn YJ, Shin HJ, Jeong EA, An HS, Lee JY, Jang HM, Kim KE, Lee J, Shin MC, Roh GS. Exendin-4 Pretreatment Attenuates Kainic Acid-Induced Hippocampal Neuronal Death. Cells 2021;10:2527. [PMID: 34685508 DOI: 10.3390/cells10102527] [Reference Citation Analysis]